Uncarboxylated Osteocalcin Levels in Patients With Metabolic Syndrome and Their Association With Metabolic Parameters

Selda Celik, Aytekin Oguz, Mehmet Uzunlulu, Ibrahim Yilmaz, Damla Kilic, Gulsum Koroglu

Abstract


Background: Uncarboxylated osteocalcin (uOCN) synthesized by osteoblasts was shown to increase insulin secretion and peripheral insulin sensitivity in pancreatic islets. The present study evaluated the uOCN levels and its association with metabolic parameters in non-diabetic patients with metabolic syndrome (MetS) to test our hypothesis that uOCN levels may be lower in MetS, which is characterized by insulin resistance.

Methods: The study included 30 patients with MetS aged 18 years and above (13 male, 17 female, mean age 39.00 ± 5.09 years) and 30 healthy controls (15 male, 15 female, mean age 36.23 ± 6.71 years). Diabetics and post-menopausal women were excluded. The International Diabetes Federation criteria were used to define MetS. Groups were compared depending on their uOCN levels, and association of uOCN with metabolic parameters was assessed.

Results: Serum u0CN levels were 5.56 ± 3.36 ng/mL in patients with MetS whereas they were 6.26 ± 2.65 ng/mL in healthy controls (P = 0.183). Serum uOCN levels showed a negative correlation with HbA1c and body mass index (r = -0.308, P = 0.017; r = -0.278, P = 0.032, respectively) in all patients, and with waist circumference (r = -0.190, P = 0.032; r = -0.379, P: 0.047, respectively) in males.

Conclusion: Although the difference in uOCN levels between patients with MetS and control group was not statistically significant, a negative correlation of uOCN with HbA1c, body mass index and waist circumference may provide support to our hypothesis that uOCN levels may be lower in MetS.




J Endocrinol Metab. 2012;2(2):82-87
doi: https://doi.org/10.4021/jem87w


Keywords


Insulin resistance; Metabolic syndrome; Uncarboxylated osteocalcin

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.